✦ LIBER ✦

Combination hepatitis B immune globulin and lamivudine versus hepatitis B immune globulin monotherapy in preventing recurrent hepatitis B virus infection in liver transplant recipients

✍ Scribed by Z Ben-Ari; E Mor; N Bar-Nathan; E Shaharabani; Z Shapira; R Tur-Kaspa

Book ID: 117233146
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 57 KB
Volume: 35
Category: Article
ISSN: 0041-1345
DOI: 10.1016/s0041-1345(03)00008-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Lamivudine after hepatitis B immune glob

Lamivudine after hepatitis B immune globulin is effective in preventing hepatitis B recurrence after liver transplantation

✍ S. Forrest Dodson; Michael E. de Vera; C. Andrew Bonham; David A. Geller; Jorge 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

An efficacy and cost-effectiveness analy

An efficacy and cost-effectiveness analysis of combination hepatitis B immune globulin and lamivudine to prevent recurrent hepatitis B after orthotopic liver transplantation compared with hepatitis B immune globulin monotherapy

✍ Steven-Huy B. Han; Joshua Ofman; Curtis Holt; Kevin King; Gregg Kunder; Pauline 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB

Prophylaxis against hepatitis B recurren

Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin

✍ Jay S. Markowitz; Paul Martin; Andrew J. Conrad; James F. Markmann; Philip Seu; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 52 KB

Patients undergoing liver transplantation for hepatitis B-related liver disease are prone to recurrence. The mainstay of prophylaxis has been passive immunotherapy with hepatitis B immune globulin (HBIG). Antiviral therapy with lamivudine has proven effective in lowering hepatitis B virus (HBV) DNA

Intramuscular hepatitis B immune globuli

Intramuscular hepatitis B immune globulin combined with lamivudine for prophylaxis against hepatitis B recurrence after liver transplantation

✍ Yao, Francis Y. ;Osorio, Robert W. ;Roberts, John P. ;Poordad, Fred F. ;Briceno, 📂 Article 📅 1999 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 59 KB

Immunoprophylaxis using intravenous (IV) hepatitis B immune globulin (HBIG) decreases the recurrence of hepatitis B virus (HBV) infection after orthotopic liver transplantation (OLT). However, IV HBIG is expensive, has significant side effects, and is inconvenient to administer. An alternative appro

Use of combined treatment of hepatitis B

Use of combined treatment of hepatitis B immune globulin and lamivudine as prevention of hepatitis B virus recurrence in liver allograft

✍ E Albeniz Arbizu; R Barcena Marugan; E Oton Nieto; M Mateo Lindeman; M Garcia Go 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Hepatitis B virus S mutants in liver tra

Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis

✍ Marc G. Ghany; Brick Ayola; Federico G. Villamil; Robert G. Gish; Sergio Rojter; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 137 KB 👁 1 views

## Long -term hepatitis B immune globulin (HBIG) has been shown to reduce hepatitis B virus (HBV) reinfection in patients transplanted for hepatitis B. The aim of this study was to determine the prevalence of HBV S gene mutations in liver transplant recipients who developed recurrent hepatitis B d